--Novartis AG (NVS) said it would supply U.S. pharmacies with its pre-filled Symjepi epinephrine shots, amid a shortage of Mylan NV's (MYL) EpiPens, Reuters reports Tuesday.

--Novartis said they would charge a wholesale price of $250 for two adult-dose syringes, the report said, adding Mylan charges $300 for its authorized generic.

--A unit of Pfizer Inc. (PFE) produces all EpiPens sold across the globe at a single plant, which had been experiencing manufacturing problems, the report said.

 

Full story: https://www.reuters.com/article/us-novartis-epipen-launch/novartis-to-sell-epinephrine-shot-in-u-s-pharmacies-amid-epipen-shortage-idUSKCN1U418X

 

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

July 09, 2019 19:15 ET (23:15 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Mylan NV Charts.
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Mylan NV Charts.